287 related articles for article (PubMed ID: 20691766)
1. Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion.
Gamboa J; Blankenship DA; Niemi JP; Landreth GE; Karl M; Hilow E; Sundararajan S
Neuroscience; 2010 Oct; 170(3):846-57. PubMed ID: 20691766
[TBL] [Abstract][Full Text] [Related]
2. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
4. Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre-clinical systematic review.
White AT; Murphy AN
J Neurochem; 2010 Nov; 115(4):845-53. PubMed ID: 20964688
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
[TBL] [Abstract][Full Text] [Related]
6. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
7. A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia.
Shimazu T; Inoue I; Araki N; Asano Y; Sawada M; Furuya D; Nagoya H; Greenberg JH
Stroke; 2005 Feb; 36(2):353-9. PubMed ID: 15618443
[TBL] [Abstract][Full Text] [Related]
8. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain.
Schmerbach K; Schefe JH; Krikov M; Müller S; Villringer A; Kintscher U; Unger T; Thoene-Reineke C
Brain Res; 2008 May; 1208():225-33. PubMed ID: 18378216
[TBL] [Abstract][Full Text] [Related]
9. Oral pioglitazone reduces infarction volume and improves neurologic function following MCAO in rats.
Blankenship D; Niemi J; Hilow E; Karl M; Sundararajan S
Adv Exp Med Biol; 2011; 701():157-62. PubMed ID: 21445783
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms.
Pereira MP; Hurtado O; Cárdenas A; Boscá L; Castillo J; Dávalos A; Vivancos J; Serena J; Lorenzo P; Lizasoain I; Moro MA
J Cereb Blood Flow Metab; 2006 Feb; 26(2):218-29. PubMed ID: 16034372
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
Gupta S; Sharma U; Jagannathan NR; Gupta YK
Exp Neurol; 2017 Feb; 288():25-37. PubMed ID: 27794423
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
Patzer A; Zhao Y; Stöck I; Gohlke P; Herdegen T; Culman J
Eur J Neurosci; 2008 Nov; 28(9):1786-94. PubMed ID: 18973594
[TBL] [Abstract][Full Text] [Related]
14. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
[TBL] [Abstract][Full Text] [Related]
15. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
[TBL] [Abstract][Full Text] [Related]
16. Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome.
Ji S; Kronenberg G; Balkaya M; Färber K; Gertz K; Kettenmann H; Endres M
Exp Neurol; 2009 Apr; 216(2):321-8. PubMed ID: 19146854
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
[TBL] [Abstract][Full Text] [Related]
18. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
[TBL] [Abstract][Full Text] [Related]
19. Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.
Caltagirone C; Cisari C; Schievano C; Di Paola R; Cordaro M; Bruschetta G; Esposito E; Cuzzocrea S;
Transl Stroke Res; 2016 Feb; 7(1):54-69. PubMed ID: 26706245
[TBL] [Abstract][Full Text] [Related]
20. Prereperfusion saline infusion into ischemic territory reduces inflammatory injury after transient middle cerebral artery occlusion in rats.
Ding Y; Li J; Rafols JA; Phillis JW; Diaz FG
Stroke; 2002 Oct; 33(10):2492-8. PubMed ID: 12364743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
